Tegument proteins of kaposi's sarcoma-associated herpesvirus and related gamma-herpesviruses

Frontiers in Microbiology

Volumn 3, Issue MAR, 2012, Pages

  Sathish, Narayanan ^a   Wang, Xin ^b   Yuan, Yan ^b  

^a INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH BHOPAL   (India)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Human herpesvirus type 8; Kaposis sarcoma associated herpesvirus; Protein interaction; Tegument; Virion; Virion assembly

Indexed keywords

EID: 84875671228     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00098     Document Type: Article

References (138)

1. Abaitua, F., and O'Hare, P. (2008). Identification of a highly conserved, functional nuclear localization signal within the N-terminal region of herpes simplex virus type 1 VP1-2 tegument protein. J. Virol. 82, 5234-5244.
2. Akula, S. M., Naranatt, P. P., Walia, N. S., Wang, F. Z., Fegley, B., and Chandran, B. (2003). Kaposi's sarcoma-associated herpesvirus (human her-pesvirus 8) infection of human fibroblast cells occurs through endo-cytosis. J. Virol. 77, 7978-7990.
3. Akula, S. M., Naranatt, P. P., Wang, F. Z.,and Chandran,B. (2001). Human herpesvirus envelope-associated glycoprotein B interacts with heparan sulfate-like moieties. Virology 284, 235-249.
4. Akula, S. M., Naranatt, P. P., Wang, F. Z., and Chandran, B. (2002). Integrin α3β1 (CD49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) entry into target cells. Cell 108, 407-419.
5. Amerik, A. Y., and Hochstrasser, M. (2004). Mechanism and function of deubiquitinating enzymes. Biochim. Biophys. Acta 1695, 189-207.
6. Antman, K., and Chang, Y. (2000). Kaposi's sarcoma. N. Engl. J. Med. 342, 1027-1038.
7. Baghian, A., Luftig, M., Black, J. B., Meng, Y. X., Pau, C. P., Voss, T., Pellett, P. E., and Kousoulas, K. G. (2000). Glycoprotein B of human herpesvirus 8 is a component of the virion in a cleaved form composed of amino- and carboxyl-terminal fragments. Virology 269, 18-25.
8. Ballestas, M. E., Chatis, P. A., and Kaye, K. M. (1999). Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284, 641-644.
9. Bechtel, J. T., Winant, R. C., and Ganem, D. (2005). Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79, 4952-4964.
10. Benach, J., Wang, L., Chen, Y., Ho, C. K., Lee, S., Seetharaman, J., Xiao, R., Acton,T. B., Montelione, G. T.,Deng, H., Sun. R., and Tong, L. (2007). Structural and functional studies of the abundant tegument protein ORF52 from murine gammaher-pesvirus 68. J. Biol. Chem. 282, 31534-31541.
11. Bernardi, R., and Pandolfi, P. P. (2007). Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 8, 1006-1016.
12. Birkmann, A., Mahr, K., Ensser, A., Yaguboglu, S., Titgemeyer, F., Fleck-enstein, B.,and Neipel, F. (2001). Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1. J. Virol. 75, 11583-11593.
13. Bortz, E., Wang, L., Jia, Q., Wu, T. T., Whitelegge, J. P., Deng, H., Zhou, Z. H., and Sun, R. (2007). Murine gammaherpesvirus 68 ORF52 encodes a tegument protein required for virion morphogenesis in the cytoplasm. J. Virol. 81, 10137-10150.
14. Bortz, E., Whitelegge, J. P., Jia, Q., Zhou, Z. H., Stewart, J. P., Wu, T.-T., and Sun, R. (2003). Identification of proteins associated with murine gammaher-pesvirus 68 virions. J. Virol. 77, 13425-13432.
15. Boutell, C., Sadis, S., and Everett, R. D. (2002). Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. J. Virol. 76, 841-850.
16. Brierley, M. M., and Fish, E. N. (2002). Review: IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry. J. Interferon Cytokine Res. 22, 835-845.
17. Brown, H. J., Song, M. J., Deng, H., Wu, T.-T., Cheng, G., and Sun, R. (2003). NF-κ-B inhibits gammaher-pesvirus lytic replication. J. Virol. 77, 8532-8540.
18. Cesarman, E., Chang, Y., Moore, P. S., Said, J. W., and Knowles, D. M. (1995a). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332, 1186-1191.
19. Cesarman, E., Moore, P. S., Rao, P. H., Inghirami, G., Knowles, D. M., and Chang, Y. (1995b). In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-l and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86, 2708-2714.
20. Cesarman, E., Mesri,E. A., and Gershengorn, M. C. (2000). Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia? J. Exp. Med. 191, 417-422.
21. Chandran, B. (2010). Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells. J. Virol. 84, 2188-2199.
22. Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper J., Knowles, D. M, and Moore, P. S. (1994). Identification of herpesvirus-like DNA sequences in AIDS associated Kaposi's sarcoma. Science 266, 1865-1869.
23. Chelbi-Alix, M. K., Pelicano, L., Quignon, F., Koken, M. H., Venturini, L., Stadler, M., Pavlovic, J., Degos, L., and de Thé, H. (1995). Induction of the PML protein by interferons in normal and APL cells. Leukemia 9, 2027-2033.
24. Chen, D., Jiang, H. H., Lee, M., Liu, F., and Zhou, Z. H. (1999). Three-dimensional visualization of tegument/capsid interactions in the intact human cytomegalovirus. Virology 260, 10-16.
25. Chuck, S., Grant, R. M., Katongole-Mbidde, E.,Conant,M.,and Ganem, D. (1996). Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma. J. Infect. Dis. 173, 248-251.
26. Chung, C., Chen, C., Ho, M., Huang, C., Liao, C., and Chang, W. (2006). Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles. J. Virol. 80, 2127-2140.
27. Connor, J. H., McKenzie, M. O., Parks, G. D., and Lyles, D. S. (2007). Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses. Virology 362, 109-119.
28. Dai, W., Jia, Q., Bortz, E., Shah, S., Liu, J., Atanasov, I., Li, X., Taylor, K. A., Sun, R., and Zhou, Z. H. (2008). Unique structures in a tumor herpesvirus revealed by cryoelectron tomography and microscopy. J. Struct. Biol. 161, 428-438.
29. de Oliveira, D. E., Ballon, G., and Cesarman, E. (2010). NF-kappaB signaling modulation by EBV and KSHV. Trends Microbiol. 18, 248-257.
30. del Rio, T., DeCoste, C. J., and Enquist, L. W. (2005). Actin is a component of the compensation mechanism in pseudorabies virus virions lacking the major tegument protein VP22. J. Virol. 79, 8614-8619.
31. Dezube, B. J. (1996). Clinical presentation and natural history of AIDS - related Kaposi's sarcoma. Hematol. Oncol. Clin. North Am. 10, 1023-1029.
32. Diefenbach, R. J., Miranda-Saksena, M., Douglas, M. W., and Cunningham, A. L. (2008). Transport and egress of herpes simplex virus in neurons. Rev. Med. Virol. 18, 35-51.
33. Döhner, K., Radtke, K., Schmidt, S., and Sodeik, B. (2006). Eclipse phase of herpes simplex virus type 1 infection: efficient dynein-mediated capsid transport without the small capsid protein VP26. J. Virol. 80, 8211-8224.
34. Douglas, M. W.,Diefenbach R. J., Homa, F. L., Miranda-Saksena, M., Rixon, F. J., Vittone, V., Byth, K., and Cunningham, A. L. (2004). Herpes simplex virus type 1 capsid protein VP26 interacts with dynein light chains RP3 and Tctex1 and plays a role in retrograde cellular transport. J. Biol. Chem. 279, 28522-28530.
35. Dupin, N., Grandadam, M., Calvez, V., Gorin, I., Aubin, J. T., Havard, S., Lamy, F., Leibowitch, M., Huraux, J. M., Escande, J. P., and Agut, H. (1995). Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 345, 761-762.
36. Everett, R. D., and Chelbi-Alix, M. K. (2007). PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89, 819-830.
37. Everett, R. D., Freemont, P., Saitoh, H., Dasso, M., Orr, A., Kathoria, M., and Parkinson, J. (1998). The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML iso-forms. J. Virol. 72, 6581-6591.
38. Feederle, R., Neuhierl, B., Baldwin, G., Bannert, H., Hub, B., Mautner, J., Behrends, U., and Delecluse, H. J. (2006). Epstein-Barr virus BNRF1 protein allows efficient transfer from the endosomal compartment to the nucleus of primary B lymphocytes. J. Virol. 80, 9435-9443.
39. Gack, M. U., Shin, Y. C., Joo C.-H., Urano, T., Liang, C., Sun, L., Takeuchi, O., Akira, S., Chen, Z., Inoue, S., and Jung, J. U. (2007). TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916-920.
40. Ganem, D. (2007). "Kaposi's sarcoma-associated herpesvirus," in Fields Virology, 5th Edn, eds D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (Philadelphia, PA: Lippincott Williams & Wilkins), 2875-2888.
41. Ganem, D. (2010). KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J. Clin. Invest. 120, 939-949.
42. Gaspar, M., Gill, M. B., Lösing, J. B., May, J. S., and Stevenson, P. G. (2008). Multiple functions for ORF75c in murid herpesvirus-4 infection. PLoS ONE 3, e2781. doi:10.1371/journal.pone.0002781
43. González, C. M., Wang, L., and Damania, B. (2009). Kaposi's sarcoma-associated herpesvirus encodes a viral deubiquitinase. J. Virol. 83, 10224-10233.
44. Goodbourn, S., Didcock, L., and Randall, R. E. (2000). Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81, 2341-2364.
45. Gredmark, S., Schlieker, C., Quesada, V., Spooner, E., and Ploegh, H. L. (2007). A functional ubiquitin-specific protease embedded in the large tegument protein (ORF64) of murine gammaherpesvirus 68 is active during the course of infection. J. Virol. 81, 10300-10309.
46. Gregory, S. M., Davis, B. K., West, J. A., Taxman, D. J., Matsuzawa, S., Reed, J. C., Ting, J. P., and Damania, B. (2011). Discovery of a viral NLR homolog that inhibits the inflamma-some. Science 331, 330-334.
47. Grossmann, C., and Ganem, D. (2008). Effects of NFκB activation on KSHV latency and lytic reactivation are complex and context-dependent. Virology 375, 94-102.
48. Grotzinger, T., Jensen, K., and Will, H. (1996). The interferon (IFN)-stimulated gene Sp100 promoter contains an IFN-gamma activation site and an imperfect IFN-stimulated response element which mediate type I IFN inducibility. J. Biol. Chem. 271, 25253-25260.
49. Grundhoff, A., and Ganem, D. (2004). Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J. Clin. Invest. 113, 124-136.
50. Guo, H., Wang, L., Peng, L., Zhou, Z. H., and Deng, H. (2009). Open reading frame 33 of a gammaherpesvirus encodes a tegument protein essential for virion morphogenesis and egress. J. Virol. 83, 10582-10595.
51. Hahn,A., Birkmann,A., Wies, E., Dorer, D., Mahr, K., Stürzl, M., Titge-meyer, F., and Neipel, F. (2009). Kaposi's sarcoma-associated her-pesvirus gH/gL: glycoprotein export and interaction with cellular receptors. J. Virol. 83, 396-407.
52. Hauge, C., and Frodin, M. (2006). RSK and MSK in MAP kinase signalling. J. Cell Sci. 119, 3021-3023.
53. Hirokawa, N. (2000). Stirring up development with the heterotrimeric kinesin KIF3. Traffic 1, 29-34.
54. Hiscott, J. (2007). Triggering the innate antiviral response through IRF-3 activation. J. Biol. Chem. 282, 15325-15329.
55. Honda, K., and Taniguchi, T. (2006). IRFs: master regulators of signaling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6, 644-658.
56. Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., and Taniguchi, T. (2005a). IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434, 772-777.
57. Honda, K., Hideyuki, Y., Takaoka, A., and Taniguchi, T. (2005b). Regulation of the type I IFN induction: a current view. Int. Immunol. 17, 1367-1378.
58. Inn, K. S., Lee, S. H., Rathbun, J. Y., Wong, L. Y., Toth, Z., Machida, K., Ou, J. H., and Jung, J. U. (2011). Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64. J. Virol. 85, 10899-10904.
59. Jenner, R. G., and Boshoff, C. (2002). The molecular pathology of Kaposi's sarcoma-associated herpesvirus. Biochim. Biophys. Acta 1602, 1-22.
60. Johannsen, E., Luftig, M., Chase, M. R., Weicksel, S., Cahir-McFarland, E., Illanes, D., Sarracino, D., and Kieff, E. (2004). Proteins of purified Epstein-Barr virus. Proc. Natl. Acad. Sci. U.S.A. 101, 16286-16291.
61. Jovasevic, V., Liang, L., and Roizman, B. (2008). Proteolytic cleavage of VP1-2 is required for release of herpes simplex virus 1 DNA into the nucleus. J. Virol. 82, 3311-3319.
62. Kaleeba, J. A., and Berger, E. A. (2006). Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT. Science 311, 1921-1924.
63. Kattenhorn, L. M., Korbel, G. A., Kessler, B. M., Spooner, E., and Ploegh, H. L. (2005). A deubiquitinating enzyme encoded by HSV-1 belongs to a family of cysteine proteases that is conserved across the family Herpesviri-dae. Mol. Cell 19, 547-557.
64. King, S. M. (2000). The dynein microtubule motor. Biochim. Biophys. Acta 1496, 60-75.
65. Konrad, A., Wies, E., Thurau, M., Marquardt, G., Naschberger, E., Hentschel, S., Jochmann, R., Schulz, T. F., Erfle, H., Brors, B., Lausen, B., Neipel, F., and Stürzl, M. (2009). A systems biology approach to identify the combination effects of human herpesvirus 8 genes on NF-kappaB activation. J. Virol. 83, 2563-2574.
66. Koyano, S., Mar,E. C., Stamey,F. R., and Inoue, N. (2003). Glycoproteins M and N of human herpesvirus 8 form a complex and inhibit cell fusion. J. Gen. Virol. 84, 1485-1491.
67. Kramer, T., Greco, T. M., Enquist, L. W., and Cristea, I. M. (2011). Proteomic characterization of pseudorabies virus extracellular virions. J. Virol. 85, 6427-6441.
68. Kuang, E., Tang, Q., Maul, G. G., and Zhu, F. (2008). Activation of p90 ribosomal S6 kinase by ORF45 of Kaposi's sarcoma-associated herpesvirus and its role in viral lytic replication. J. Virol. 82, 1838-1850.
69. Kuang, E., Wu, F., and Zhu, F. (2009). Mechanism of sustained activation of ribosomal S6 kinase (RSK) and ERK by kaposi sarcoma-associated herpesvirus ORF45: multiprotein complexes retain active phospho-rylated ERK AND RSK and protect them from dephosphorylation. J. Biol. Chem. 284, 13958-13968.
70. Lavau, C., Marchio, A., Fagioli, M., Jansen, J., Falini, B., Lebon, P., Grosveld, F., Pandolfi, P. P., Pelicci, P. G., and Dejean,A. (1995). The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene 11, 871-876.
71. Ling, P. D., Tan, J., Sewatanon, J., and Peng, R. (2008). Murine gamma-herpesvirus 68 open reading frame 75c tegument protein induces the degradation of PML and is essential for production of infectious virus. J. Virol. 82, 8000-8012.
72. Liu, Y., Cui, Z., Zhang, Z., Wei, H., Zhou, Y., Wang, M., and Zhang, X. E. (2009). The tegument protein UL94 of human cytomegalovirus as a binding partner for tegument protein pp28 identified by intracellular imaging. Virology 388, 68-77.
73. Loret, S., Guay, G., and Lippé, R. (2008). Comprehensive characterization of extracellular herpes simplex virus type 1 virions. J. Virol. 82, 8605-8618.
74. Lukashchuk, V., McFarlane, S., Everett, R. D., and Preston, C. M. (2008). Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection. J. Virol. 82, 12543-12554.
75. Luxton, G. W., Haverlock, S., Coller, K. E., Antinone, S. E., Pincetic, A., and Smith, G. A. (2005). Targeting of herpesvirus capsid transport in axons is coupled to association with specific sets of tegument proteins. Proc. Natl. Acad. Sci. U.S.A. 102, 5832-5837.
76. Mandelkow, E., and Mandelkow, E. M. (1995). Microtubules and microtubule-associated proteins. Curr. Opin. Cell Biol. 7, 72-81.
77. Martin, D. F., Kuppermann, B. D., Wolitz, R. A., Palestine, A. G., Li, H. and Robinson, C. A. (1999). Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N. Engl. J. Med. 340, 1063-1070.
78. Martinon, F., Burns, K., and Tschopp, J. (2002). The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10, 417-426.
79. Maul, G. G., Guldner, H. H., and Spivack, J. G. (1993). Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J. Gen. Virol. 74, 2679-2690.
80. May, J. S., Coleman, H. M., Boname, J. M., and Stevenson, P. G. (2005a). Murine gammaherpesvirus-68 ORF28 encodes a non-essential virion glycoprotein. J. Gen. Virol. 86, 919-928.
81. May, J. S., Walker, J., Colaco, S., and Stevenson, P. G. (2005b). The murine gammaherpesvirus 68 ORF27 gene product contributes to intercellular viral spread. J. Virol. 79, 5059-5068.
82. McNabb, D., and Courtney, R. (1992). Characterization of the large tegument protein (ICP1/2) of herpes simplex virus type 1. Virology 190, 221-232.
83. Meckes, D. G. Jr., and Wills, J. W. (2007). Dynamic interactions of the UL16 tegument protein with the capsid of herpes simplex virus. J. Virol. 81, 13028-13036.
84. Mettenleiter, T. C. (2002). Herpesvirus assembly and egress. J. Virol. 76, 1537-1547.
85. Mettenleiter, T. C., Klupp, B. G., and Granzow, H. (2009). Herpesvirus assembly: an update. Virus Res. 143, 222-234.
86. Meylan, E., Tschopp, J., and Karin, M. (2006). Intracellular pattern recognition receptorsinthe host response. Nature 442, 39-44.
87. Miller, G., Heston, L., Grogan, E., Gradoville, L., Rigsby, M., Sun, R., Shedd, D., Kushnaryov,V. M., Grossberg, S., and Chang,Y. (1997). Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lym-phoma cells. J. Virol. 71, 314-324.
88. Moore, P. S., and Chang, Y. (1995). Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N. Engl. J. Med. 332, 1181-1185.
89. Moore, P. S., Gao, S. J., Dominguez, G., Cesarman, E., Lungu, O., Knowles, D. M., Garber, R., Pellett, P. E., McGeoch, D. J., and Chang, Y. (1996). Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J. Virol. 70, 549-558.
90. Morfeldt, L., and Torssander, J. (1994). Long-term remission of Kaposi's sarcoma following foscarnet treatment in HIV-infected patients. Scand. J. Infect. Dis. 26, 749-752.
91. Nakagawa, S., Umehara, T., Matsuda, C., Kuge, S., Sudoh, M., and Kohara, M. (2007). Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice. Biochem. Biophys. Res. Commun. 353, 882-888.
92. Naranatt, P. P., Akula, S. M., and Chandran, B. (2002). Characterization of gamma2-human herpesvirus-8 gly-coproteins gH and gL. Arch. Virol. 147, 1349-1370.
93. Naranatt, P. P., Krishnan, H. H., Smith, M. S., and Chandran, B. (2005). Kaposi's sarcoma-associated herpesvirus modulates micro-tubule dynamics via RhoA-GTP diaphanous 2 signaling and utilizes the dynein motors to deliver its DNA to the nucleus. J. Virol. 79, 1191-1206.
94. Naranatt, P. P., Krishnan, H. H., Svojanovsky, S. R., Bloomer, C., Mathur, S., and Chandran, B. (2004). Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated her-pesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection. Cancer Res. 64, 72-84.
95. Nealon, K., Newcomb, W. W., Pray, T. R., Craik, C. S., Brown, J. C., and Kedes, D. H. (2001). Lytic replication of Kaposi's sarcoma-associated herpesvirus results in the formation of multiple capsid species: isolation and molecular characterization of A, B, and C capsids from a gammaher-pesvirus. J. Virol. 75, 2866-2878.
96. Newcomb, W. W., and Brown, J. C. (2010). Structure and capsid association of the herpesvirus large tegument protein UL36. J. Virol. 84, 9408-9414.
97. Ogawa-Goto, K., Tanaka, K., Gibson, W., Moriishi, E., Miura, Y., Kurata, T., Irie, S., and Sata, T. (2003). Microtubule network facilitates nuclear targeting of human cytomegalovirus capsid. J. Virol. 77, 8541-8547.
98. Pellet, P. E., and Roizman, B. (2007). "The family Herpesviridae: a brief introduction," in Fields' Virology, 5th Edn, eds D. M. Knipe, P. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (New York, NY: Lippincott Williams & Wilkins), 2479-2499.
99. Perry, S. T., and Compton, T. (2006). Kaposi's sarcoma-associated her-pesvirus virions inhibit interferon responses induced by envelope gly-coprotein gpK8.1. J. Virol. 80, 11105-11114.
100. Phillips, S. L., and Bresnahan, W. A. (2011). Identification of binary interactions between human cytomegalovirus virion proteins. J. Virol. 85, 440-447.
101. Raghu, H., Sharma-Walia, N., Valiya Veettil, M., Sadagopan, S., Caballero, A., Sivakumar, R., Varga, L., Bottero, V., and Chandran, B. (2007). Lipid rafts of primary endothelial cells are essential for Kaposi's sarcoma-associated herpesvirus/human her-pesvirus 8-induced phosphatidyli-nositol 3-kinase and RhoA-GTPases critical for microtubule dynamics and nuclear delivery of viral DNA but dispensable for binding and entry. J. Virol. 81, 7941-7959.
102. Raghu, H., Sharma-Walia, N., Valiya Veettil, M., Sadagopan, S., and Chandran, B. (2009). Kaposi's sarcoma associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells. J. Virol. 83, 4895-4911.
103. Rasmussen, S. B., Jensen, S. B., Nielsen, C., Quartin, E., Kato, H., Chen, Z. J., Silverman, R. H., Akira, S., and Paludan, S. R. (2009). Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible gene-like receptors, which synergize to induce type I interferon production. J. Gen. Virol. 90, 74-78.
104. Renne, R., Zhong, W., Herndier, B., McGrath, M., Abbey, N., Kedes, D., and Ganem, D. (1996). Lytic growth of Kaposi's sarcoma-associated her-pesvirus (human herpesvirus 8) in culture. Nat. Med. 2, 342-346.
105. Roux, P. P., and Blenis, J. (2004). ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68, 320-344.
106. Rozen, R., Sathish, N., Li, Y., and Yuan, Y. (2008). Virion-wide protein interactions of Kaposi's sarcoma-associated herpesvirus. J. Virol. 82, 4742-4750.
107. Russo, J. J., Bohenzky, R. A., Chien, M. C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edelman, I. S., Chang, Y., and Moore, P. S. (1996). Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA 93, 14862-14867.
108. Sadler, A. J., and Williams, B. R. G. (2008). Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8, 559-568.
109. Samanta, M., Iwakiri, D., Kanda, T., Imaizumi, T., and Takada, K. (2006). EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J. 25, 4207-4214.
110. Samanta, M., Iwakiri, D., and Takada, K. (2008). Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. Oncogene 27, 4150-4160.
111. Sarid, R., Flore, O., Bohenzky, R. A., Chang, Y., and Moore, P. S. (1998). Transcription mapping of the Kaposi's sarcoma-associated her-pesvirus (human herpesvirus 8) genome in a body cavity-based lym-phoma cell line (BC-1). J. Virol. 72, 1005-1012.
112. Sathish, N., and Yuan, Y. (2010). Functional characterization of Kaposi's sarcoma-associated herpesvirus small capsid protein by bacterial artificial chromosome-based mutagenesis. Virology 407, 306-318.
113. Sathish, N., and Yuan, Y. (2011). Evasion and subversion of interferon-mediated antiviral immunity by Kaposi's sarcoma-associated her-pesvirus: an overview. J. Virol. 85, 10934-10944.
114. Sathish, N., Zhu, F. X., Golub, E. E., Liang, Q., and Yuan, Y. (2011). Mechanisms of autoinhibition of IRF-7 and a probable model for inactivation of IRF-7 by Kaposi's sarcoma-associated herpesvirus protein ORF45. J. Biol. Chem. 286, 746-756.
115. Sathish, N., Zhu, F. X., and Yuan, Y. (2009). Kaposi's sarcoma-associated herpesvirus ORF45 interacts with kinesin-2 transporting viral capsid- tegument complexes along micro-tubules. PLoS Pathog. 5, e1000332. doi:10.1371/journal.ppat.1000332
116. Schalling, M., Ekman, M., Kaaya, E. E., Linde, A., and Biberfeld, P. (1995). A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat. Med. 1, 707-708.
117. Shanda, S. K., and Wilson, D. W. (2008). UL36p is required for efficient transport of membrane-associated herpes simplex virus type 1 along micro-tubules. J. Virol. 82, 7388-7394.
118. Sharma-Walia, N., Krishnan, H. H., Naranatt, P. P., Zeng, L., Smith, M. S., and Chandran, B. (2005). ERK1/2 and MEK1/2 induced by Kaposi's sarcoma associated her-pesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. J. Virol. 79, 10308-10329.
119. Sharma-Walia, N., Naranatt,P. P.,Krishnan, H. H., Zeng, L., and Chandran, B. (2004). Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase rho GTPase signal pathways and cytoskeletal rearrangements. J. Virol. 78, 4207-4223.
120. Sompallae, R., Gastaldello, S., Hildebrand, S., Zinin, N., Hassink, G., Lindsten, K., Haas, J., Persson, B., and Masucci, M. G. (2008). Epstein- Barr virus encodes three bona fide ubiquitin-specific proteases. J. Virol. 82, 10477-10486.
121. Soulier, J., Grollet, L., Okshendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., d'Agay, M. F., Clauvel, J.-P., Raphael, M., Degos, L., and Sigaux,F. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86, 1276-1280.
122. Stutz, A., Golenbock, D. T., and Latz, E. (2009). Inflammasomes: too big to miss. J. Clin. Invest. 119, 3502-3511.
123. Sun, R., Lin, S. F., Staskus, K., Gradoville, L., Grogan, E., Hasse, A., and Miller, G. (1999). Kinetics of Kaposi's sarcoma-associated her-pesvirus gene expression. J. Virol. 73, 2232-2242.
124. Tsai, K., Thikmyanova, N., Wojce-chowskyj, J. A., Delecluse, H. J., and Lieberman, P. M. (2011). EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcription. PLoS Pathog. 7, e1002376. doi:10.1371/journal.ppat.1002376
125. Veettil, M. V., Sadagopan, S., Sharma-Walia, N., Wang, F.-Z., Raghu, H., Varga, L., and Chandran, B. (2008). Kaposi's sarcoma-associated herpesvirus forms a multimolec-ular complex of integrins (αvβ5, αvβ3, and α3β1) and CD98-xCT during infection of human dermal microvascular endothelial cells, and CD98-xCT is essential for the postentry stage of infection. J. Virol. 82, 12126-12144.
126. Veettil, M. V., Sharma-Walia, N., Sadagopan, S., Raghu, H., Sivakumar, R., Naranatt, P. P., and Chandran, B. (2006). RhoA-GTPase facilitates entry of Kaposi's sarcoma-associated herpesvirus into adherent target cells in a Src-dependent manner. J. Virol. 80, 11432-11446.
127. Vittone, V., Diefenbach, E., Triffett, D., Douglas, M. W., Cunningham, A. L., and Diefenbach, R. J. (2005). Determination of interactions between tegument proteins of herpes simplex virus type 1. J. Virol. 79, 9566-9571.
128. Wang,F.Z.,Akula,S. M., Pramod,N. O., Zeng, L., and Chandran, B. (2001). Human herpesvirus 8 envelope gly-coprotein K8.1 interaction with the target cells involves heparan sulfate. J. Virol. 75, 7517-7527.
129. Wang, J., Loveland, A. N., Kattenhorn, L. M., Ploegh, H. L., and Gibson,W. (2006). High-molecular-weight protein (pUL48) of human cytomegalovirus is a competent deubiquitinating protease: mutant viruses altered in its active-site cysteine or histidine are viable. J. Virol. 80, 6003-6012.
130. Wolfstein, A., Nagel, C. H., Radtke, K., Döhner, K., Allan, V. J., and Sodeik, B. (2006). The inner tegument promotes herpes simplex virus capsid motility along microtubules in vitro. Traffic 7, 227-237.
131. Yamazaki, H., Nakata, T., Okada, Y., and Hirokawa, N. (1995). KIF3A/B: a heterodimeric kinesin superfamily protein that works as a microtubule plus end-directed motor for membrane organelle transport. J. Cell Biol. 130, 1387-1399.
132. Zhong, W., Wang, H., Herndier, B., and Ganem, D. (1996). Restricted expression of Kaposi sarcoma-associated herpesvirus (human her-pesvirus 8) genes in Kaposi sarcoma. Proc. Natl. Acad. Sci. U.S.A. 93, 6641-6646.
133. Zhou, Z., Chen, D., Jakana, J., Rixon, F. J., and Chiu, W. (1999). Visualization of tegument-capsid interactions and DNA in intact herpes simplex virus type 1 virions. J. Virol. 73, 3210-3218.
134. Zhu, F. X., Chong, J. M., Wu, L., and Yuan, Y. (2005). Virion proteins of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79, 800-811.
135. Zhu, F. X., King, S. M., Smith, E. J., Levy, D. E., and Yuan,Y. (2002). A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc. Natl. Acad. Sci. U.S.A. 99, 5573-5578.
136. Zhu, F. X., Li, X., Zhou, F., Gao, S. J., and Yuan, Y. (2006). Functional characterization of Kaposi's sarcoma-associated herpesvirus ORF45 by bacterial artificial chromosome-based mutagenesis. J. Virol. 80, 12187-12196.
137. Zhu, F. X., Sathish, N., and Yuan, Y. (2010). Antagonism of host antiviral responses by Kaposi's sarcoma-associated herpesvirus tegument protein ORF45. PLoS ONE 5, e10573. doi:10.1371/journal.pone.0010573
138. Zhu, F. X., and Yuan, Y. (2003). The ORF45 protein of Kaposi's sarcoma-associated herpesvirus is associated with purified virion. J. Virol. 77, 4221-4230.